GPT Healthcare Limited — Investor Meet, 12-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance:** GPT Healthcare reported its financial results for the quarter ended December 31, 2024. Key figures indicated strong revenue growth of 15% year-over-year, reaching ₹150 crore (cr). The gross profit margin improved to 42%, reflecting efficient cost management; net profit showed a healthy increase of 18%, resulting in an earnings per share (EPS) of ₹3.50. Comparatively, these figures mark a favorable shift from the previous quarter, showcasing robust financial health.

2. **Future Outlook and Growth Drivers:** Management emphasized a strategic focus on expanding service lines and geographic presence, anticipating growing demand in tier-2 and tier-3 cities. Plans for new facility launches and enhanced technology integration were highlighted as crucial growth drivers.

3. **Order Book and Operational Updates:** The order book remains strong, bolstered by several recent contracts valued at ₹50 crore (cr). Project timelines are on schedule, with two significant projects expected to commence in Q2 2025, enhancing operational capacity.

4. **Analyst Q&A Insights (Detailed):**

- *Revenue and Profitability:* Analysts inquired about revenue sustainability; management noted increased patient volumes and new service offerings as key factors.

- *Market Position and Competitive Landscape:* Queries regarding market competition prompted insights about maintaining a competitive edge through innovation and customer service excellence.

- *Operational Challenges or Risks:* Supply chain challenges were acknowledged, though management expressed confidence in mitigating these through strategic partnerships.

- *Capex and Capital Allocation:* Analysts raised concerns about capital expenditure; management confirmed ongoing investments in technology and infrastructure aimed at long-term growth.

- *Strategic Priorities and Long-Term Vision:* Discussions centered around sustainability initiatives and digital health solutions, showing alignment with broader market trends.

5. **Market or Regulatory Updates:** No significant regulatory changes were reported, but management remains vigilant to adapt to any evolving market conditions.

6. **Strategic Focus Areas:** The call underscored a commitment to innovation and expansion while addressing cost control measures, signaling a proactive approach to future market conditions.

7. **Investor Insight:** The company's solid financial performance and strategic initiatives present a positive outlook, suggesting a potential ‘buy’ position among investors, though caution is advised due to operational risks.